Mark McDade

Companies

• Tourmaline Bio, Inc.Board member May 6, 2021 to now¹
• Icosavax, Inc.Board member Apr 5, 2022 to Jun 8, 2023²
• Aimmune Therapeutics (United Kingdom)Board member Aug 5, 2015 to Oct 14, 2020³
• Dermira (United States)Board member Oct 2, 2014 to Feb 24, 2020⁴
• CytokineticsBoard member May 26, 2006 to May 22, 2009⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IIcosavax, Inc.0 shares⁶Feb 19, 2024
• TBTourmaline Bio, Inc.0 shares⁷Oct 28, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Oct 28, 2025U 448,431 shares of Tourmaline Bio, Inc.⁷
• Oct 28, 2025U 110,083 shares of Tourmaline Bio, Inc.⁷
• Oct 28, 2025U 183,177 shares of Tourmaline Bio, Inc.⁷
• Oct 28, 2025U 518 shares of Tourmaline Bio, Inc.⁷
• Feb 19, 2024U 3,510,228 shares of Icosavax, Inc.⁶
• Feb 19, 2024U 55,786 shares of Icosavax, Inc.⁶
• Jan 29, 2024Bought 100,000 shares at $32.50 of Tourmaline Bio, Inc.⁸
• Oct 19, 2023Granted 518 shares of Tourmaline Bio, Inc.⁹
• Oct 19, 2023Granted 348,431 shares of Tourmaline Bio, Inc.⁹
• Jun 10, 2022Granted 5,543 shares of Icosavax, Inc.¹⁰
• Apr 1, 2022Bought 42,225 shares at $7.10 of Icosavax, Inc.¹¹